We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Obesity Strongly Linked to Cancer Death Risk

By HospiMedica staff writers
Posted on 15 May 2003
In the largest study of its kind, researchers have found that overweight and obesity could account for 14% of all US cancer deaths in men and 20% of those in women, for a total of 90,000 cancer deaths a year. More...
The study was published in the April 24, 2003, issue of The New England Journal of Medicine.

The researchers, from the American Cancer Society (ACS, Atlanta, USA), identified many forms of cancer not previously linked to unhealthy body weight. These included stomach (in men), liver, pancreas, prostate, cervix, and ovarian cancer as well as non-Hodgkin lymphoma and multiple myeloma. The findings also substantiated previous studies linking overweight and obesity to cancers of the colon and rectum, breast (in postmenopausal women), uterus, kidney, esophagus, and gallbladder.

The study involved more than 900,000 US adults who were free of cancer at enrollment in 1982. During the 16-year follow-up period, there were 57,145 deaths from cancer. The researchers examined the relationship between BMI (a measure of body fat based on height and weight) and subsequent risk of death from all cancers, while controlling for other risk factors such as smoking.

"Many Americans have not acknowledged the contribution of obesity to chronic disease in general and to cancer in particular,” said lead author Eugenia E. Calle, Ph.D., director of analytic epidemiology for the American Cancer Society. "For example, women are very concerned about breast cancer, but few understand that obesity doubles their risk of getting and dying from the disease.”


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.